Gilead Sciences Market Cap

Gilead Sciences has a market cap or net worth of 987.55 billion as of February 6, 2026. Its market cap has increased by 44.09% in one year.

Market Cap

987.55B

Enterprise Value

1.06T

Revenue

155.02B

Ranking

n/a

PE Ratio

22.85

Stock Price

395.48

Market Cap Chart

Since January 22, 1992, Gilead Sciences's market cap has increased from 240.84M to 987.55B, an increase of 409,943.59%. That is a compound annual growth rate of 27.66%.

Market Cap History

Date	Market Cap	% Change
Feb 6, 2026	987.55B	17.74%
Dec 31, 2025	838.76B	17.81%
Dec 31, 2024	711.99B	45.36%
Dec 29, 2023	489.80B	-13.96%
Dec 30, 2022	569.24B	12.17%
Dec 31, 2021	507.47B	33.81%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Rede D'Or São Luiz	91.65B
Raia Drogasil	46.56B
Hypera	14.97B
Fleury	9.23B
Odontoprev	6.46B
Diagnósticos da América	5.27B
Empreendimentos Pague Menos	4.17B
Oncoclínicas do Brasil Serviços Médicos	2.77B

Market Cap Rankings